BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7203964)

  • 1. Interpretation of particle growth and aggregation patterns obtained from the Coulter counter: a simple theoretical model.
    Ryall RL; Ryall RG; Marshall VR
    Invest Urol; 1981 Mar; 18(5):396-400. PubMed ID: 7203964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent assessment of the growth and aggregation of calcium oxalate crystals using the Coulter counter.
    Ryall RL; Bagley CJ; Marshall VR
    Invest Urol; 1981 Mar; 18(5):401-5. PubMed ID: 7203965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of kanpou medicine on the growth and aggregation of calcium oxalate crystals in vitro].
    Utsunomiya M; Koide T; Yamaguchi S; Yoshioka T; Sonoda T; Sugiyama K
    Hinyokika Kiyo; 1991 Oct; 37(10):1097-101. PubMed ID: 1755397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The inhibitory effects of Takusha on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Kawamura K; Moriyama M; Nakajima C; Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1993 Aug; 39(8):695-700. PubMed ID: 8379469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium oxalate crystallization in urine of healthy men and women: a comparative study.
    Buchholz NP; Kim DS; Grover PK; Ryall RL
    Scanning Microsc; 1996; 10(2):435-42; discussion 442-4. PubMed ID: 9813622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity.
    Grover PK; Ryall RL
    Clin Sci (Lond); 2002 Apr; 102(4):425-34. PubMed ID: 11914105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of seed crystals on calcium oxalate nucleation.
    Burns JR; Finlayson B
    Invest Urol; 1980 Sep; 18(2):133-6. PubMed ID: 7410024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium oxalate crystallization kinetics studied by oxalate-induced turbidity in fresh human urine and artificial urine.
    Kavanagh JP; Jones L; Rao PN
    Clin Sci (Lond); 2000 Feb; 98(2):151-8. PubMed ID: 10657269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of oral administration of Takusya on calcium oxalate crystallization in human whole urine].
    Honda M; Yoshimura K; Miyake O; Yoshioka T; Okuyama A; Yamaguchi S; Utsunomiya M; Koide T; Sugiyama K
    Hinyokika Kiyo; 1997 May; 43(5):333-7. PubMed ID: 9208316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nucleation and growth kinetics of calcium oxalate in the presence of some synthetic urine constituents.
    Rodgers AL; Garside J
    Invest Urol; 1981 May; 18(8):484-8. PubMed ID: 7228583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium oxalate crystal growth. A new constant composition method for modelling urinary stone formation.
    Sheehan ME; Nancollas GH
    Invest Urol; 1980 May; 17(6):446-50. PubMed ID: 7372431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
    Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
    J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the role of urinary macromolecules in urolithiasis: review of methodologies and a proposal for a standard reference crystallization system.
    Rodgers AL; Jappie D
    Scanning Microsc; 1996; 10(2):535-45; discussion 545-6. PubMed ID: 9813630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
    Saw NK; Chow K; Rao PN; Kavanagh JP
    J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitaxial considerations in urinary stone formation. I. The urate-oxalate-phosphate system.
    Koutsoukos PG; Lam-Erwin CY; Nancollas GH
    Invest Urol; 1980 Sep; 18(2):178-84. PubMed ID: 7410035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Method for assessment of distribution of UHMWPE wear particles in periprosthetic tissues in total hip arthroplasty].
    Pokorný D; Slouf M; Horák Z; Jahoda D; Entlicher G; Eklová S; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Aug; 73(4):243-50. PubMed ID: 17026883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of crystal growth of calcium oxalate in gel and its modification by urinary constituents in a new flow model of crystallization.
    Achilles W; Freitag R; Kiss B; Riedmiller H
    J Urol; 1995 Oct; 154(4):1552-6. PubMed ID: 7658589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.